This medication isnt a miracle drug and doesnt prevent weight gain from happening after you get off of it
Because dual incretin agonists improve metabolic dysfunction so effectively, pharmaceutical firms are heavily investing in label expansions and pipeline drugs, like emerging triple-incretin agonists
Still, with prescriptions surging, GLP-1 drugmakers must prepare for tougher scrutiny and calls from the government, doctors, and patients alike to make treatments more affordable
It may mean your current dose is still giving you benefit, and your body needs more time before moving up
Although these facilities are highly regulated, the medications are not FDA-approved or evaluated for safety, efficacy, or quality
Consumer demand is exploding , making hair restoration a multi-billion-dollar industry